Stealth Biotherapeutics Corp (NASDAQ: MITO) Has Joined the Rare Disease Company Alliance

July 9, 2021

Stealth Biotherapeutics Corp (NASDAQ: MITO) has joined an alliance for life science companies focusing on rare diseases treatments discovery, development, and delivery to Rare Disease Company Coalition patients.  Coalition to advocate for better prescription drugs pricing laws Reenie McCarthy, Stealth CEO, said, “We are thrilled to be a part of the first-of-its-kind Rare Disease Company Coalition, which is focused on supporting rare disease patients through the development of innovative therapeutics….

Read More >>